Important: Formulation and dosage details
Formulation:
Eye drops 0·1% (s)
Dosage:
Eye drops, apply 1 drop 4 times daily; uncontrolled inflammation up to every hour until controlled then reduce frequency.
test announcement
24/02/22 - loteprednol etabonate 0.5% eye drops added to the Formulary for the off-label indication of chronic anterior uveitis in patients who had a previous corticosteroid-related rise in intraocular pressure (IOP).
Topical corticosteroids should normally only be used under expert supervision for the short-term treatment of local inflammation. Prescribers must be certain of the diagnosis before prescribing topical corticosteroids as their use may aggravate dendritic ulcers caused by herpes simplex and, in patients predisposed to simple glaucoma, a 'steroid glaucoma' may be produced. Fluorometholone is less likely to cause 'steroid glaucoma'.
Please consider if a steroid emergency card needs to be given to the patient alongside the traditional steroid treatment card. This is to support the timely recognition and treatment of potential adrenal crisis and is suitable for some patients on oral, inhaled, topical or rectal steroids. For more information, including which patients should receive the card, see HIS for details. Steroid emergency cards have been distributed to, hospitals, GP surgeries and community pharmacies. Primary care can order replacement cards from 01463 706886.
See Peri-operative guidelines for patients with or at risk of adrenal insufficiency
Eye drops 0·1% (s)
Apply 1 drop 4 to 6 times daily; severe conditions every 30 to 60 minutes until controlled then reduce frequency.
Preservative-free eye drops 0·1% (s)
Apply 1 drop 4 to 6 times daily; severe conditions every 30 to 60 minutes until controlled then reduce frequency.
Eye drops 0·5% as sodium phosphate, 1% as acetate (s)
Apply 1 drop 4 to 6 times daily; severe conditions every 30 to 60 minutes until controlled then reduce frequency.
Preservative-free eye drops 0·5% as sodium phosphate (s)
Eye drops 0.5% off-label (specialist initiation only)
For the off-label use in chronic anterior uveitis in patients who had a previous corticosteroid-related rise in intraocular pressure (IOP).